Home

Job Opportunities
(as of 23rd October 2008)

Currently no vacancies

We are always seeking exceptional candidates

Contact us


Latest News

01.01.08 01:10

MedSpray: The Next Generation in Topical Drug Delivery

MedSpray: The Next Generation in Topical Drug Delivery  by Dr. Marc Brown, C.S.O., Drug...

01.11.07 07:02

Press Release announcing successful progression of MedSpray clinical trial November 2007

MedSpray ‘Patch in a Can®’ technology advances towards Phase II clinical evaluation in Athlete’s...

01.07.07 00:57

Treatment of Fungal Nail Infections

Review article written by Prof Marc Brown and Dr Matt Traynor published in Drug Delivery Report...

01.03.07 01:13

A multi-model approach for the evaluation of topical antifungal agents and formulations for the treatment of onychomycosis

A multi-model approach for the evaluation of topical antifungal agents and formulations for the...

01.01.07 01:15

Reformulation trend capturing Pharma

Reformulation trend capturing Pharma by Kirsty Barnes, in-pharmatechnologist.com, 17th January 2007.

Drug Delivery with a Difference.

MedPharm is a private drug delivery and contract service company committed to the creation and development of novel systems, particularly for topical drug formulations for delivery to the skin, nail, mucous membranes, eye, nose and lung.

We have a reputation for success with formulating difficult compounds especially in the area of topical drug delivery.

With over 100 customers worldwide, MedPharm offers a unique and highly specialized service in pharmaceutical contract research and development, and expert project management from feasibility tests, dosage design and optimization, to preparation of GMP clinical supplies trials and preclinical (GLP and non-GLP) and clinical evaluation.

MedPharm has a substantial patent portfolio of novel drug delivery systems. These technologies are available as part of our service offering or as stand-alone licences to third parties.


MedPharm: Your partner in topical drug delivery and formulation.